Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation

Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation

US Patent 10300048 · Granted May 28, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimicrobial tailored chitosan2025
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2020
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2020
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2020
Inhibitor of endocannabinoid cellular reuptake2019
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2019
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2019
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2019
Antimicrobial peptide dendrimers2019
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2018
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2018
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellula2018